Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03238625Phase 2Completed
Phase 2, randomised, double-blind trial of sodium bicarbonate, sponsored by University of Zurich. Primary endpoint: Rating of injection pain between IMP1 and IMP2 at 1 month. Started Aug 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03238625.